Cargando…
PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway
BACKGROUND: Chemoresistance is emerging as a major barrier to successful treatment in acute myeloid leukemia (AML), and bone marrow stromal cells (BMSCs) protect leukemia cells from chemotherapy eventually leading to recurrence. This study was designed to investigate the role of p21-activated kinase...
Autores principales: | Li, Banban, Jia, Ruinan, Li, Wei, Zhou, Ying, Guo, Dongmei, Teng, Qingliang, Du, Shenghong, Li, Mingying, Li, Wěi, Sun, Tao, Ma, Daoxin, Ji, Min, Ji, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297649/ https://www.ncbi.nlm.nih.gov/pubmed/34307365 http://dx.doi.org/10.3389/fcell.2021.686695 |
Ejemplares similares
-
The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia
por: Su, Xiuhua, et al.
Publicado: (2022) -
Severe aplastic anemia preceding acute monocytic leukemia in an adult with acquired trisomy 21: A case report
por: GUO, DONGMEI, et al.
Publicado: (2014) -
Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022) -
Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia
por: Chen, Chen, et al.
Publicado: (2016) -
DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2023)